CVX Vs XOM Stock, Which Energy Play Is Best?
Chevron (NYSE:CVX) and Exxon Mobil (NYSE:XOM) are two of the…
Sell
42
AMN Quote, Financials, Valuation and Earnings
Last price:
$19.63
Seasonality move
:
7.21%
Day range:
$19.47 - $20.00
52-week range:
$17.45 - $70.07
Dividend yield:
0%
P/E ratio:
18.72x
P/S ratio:
0.25x
P/B ratio:
1.06x
Volume:
803.6K
Avg. volume:
935K
1-year change:
-67.32%
Market cap:
$747.7M
Revenue:
$3B
EPS (TTM):
-$3.85
Analysts' Opinion
-
Consensus RatingAMN Healthcare Services has received a consensus rating of Hold. The company's average rating is a Hold based on 1 Buy rating, 5 Hold ratings, and 0 Sell ratings.
-
Price Target UpsideAccording to analysts' consensus price target of $28.57, AMN Healthcare Services has an estimated upside of 45.92% from its current price of $19.58.
-
Price Target DownsideAccording to analysts, the lowest downside price target is $25.00 representing 100% downside risk from its current price of $19.58.
Fair Value
-
According to the consensus of 6 analysts, AMN Healthcare Services has 45.92% upside to fair value with a price target of $28.57 per share.
AMN vs. S&P 500
-
Over the past 5 trading days, AMN Healthcare Services has underperformed the S&P 500 by -2.97% suggesting its relative strength compared to the major market average is weak at this time.
Share Buyback
-
AMN Healthcare Services does have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.
Revenue Growth
-
AMN Healthcare Services revenues have been falling on a year-over-year basis for 9 quarters in a row. In the most recent quarter AMN Healthcare Services reported revenues of $734.7M.
Earnings Growth
-
AMN Healthcare Services earnings have been falling on a year-over-year basis for 8 quarters in a row. In the most recent quarter AMN Healthcare Services reported earnings per share of -$4.90.
Enterprise value:
1.8B
EV / Invested capital:
--
Price / LTM sales:
0.25x
EV / EBIT:
15.55x
EV / Revenue:
0.60x
PEG ratio (5yr expected):
--
EV / Free cash flow:
7.49x
Price / Operating cash flow:
3.13x
Enterprise value / EBITDA:
25.22x
Gross Profit (TTM):
$919.4M
Return On Assets:
-5.38%
Net Income Margin (TTM):
-4.93%
Return On Equity:
-17.67%
Return On Invested Capital:
-7.27%
Operating Margin:
2.71%
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2023-12-31 | 2024-12-31 | |
| Income Statement | ||||||
| Revenue | $5.2B | $3.8B | $3B | $818.3M | $734.7M | |
| Gross Profit | $1.7B | $1.2B | $919.4M | $260.9M | $219M | |
| Operating Income | $647.1M | $338.4M | $119.8M | $34.2M | $19.9M | |
| EBITDA | $784.2M | $499.4M | $71.1M | $77.3M | -$161.1M | |
| Diluted EPS | $9.84 | $5.29 | -$3.85 | $0.33 | -$4.90 | |
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | $533.7M | $1.3B | $1.1B | $841.7M | $594.9M | |
| Total Assets | $2.4B | $3.1B | $2.9B | $2.9B | $2.4B | |
| Current Liabilities | $423M | $969.4M | $857.9M | $656.1M | $545.8M | |
| Total Liabilities | $1.5B | $2B | $1.8B | $2.1B | $1.7B | |
| Total Equity | $819.7M | $1.2B | $1B | $831.3M | $706.6M | |
| Total Debt | $862.6M | $842.3M | $843.5M | $1.3B | $1.1B | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2023-12-31 | 2024-12-31 | |
| Cash Flow Statement | ||||||
| Cash Flow Operations | $653.7M | $372.2M | $320.4M | -$41.1M | $72.8M | |
| Cash From Investing | -$170.7M | -$412.5M | -$79.9M | -$323.7M | -$14.2M | |
| Cash From Financing | -$591.9M | $10.7M | -$259.4M | $363.5M | -$79.9M | |
| Free Cash Flow | $572.8M | $266.8M | $239.5M | -$72.7M | $56.6M | |
AMN
Sector
Market Cap
$747.7M
$34.5M
Price % of 52-Week High
27.94%
43.57%
Dividend Yield
0%
0%
Shareholder Yield
-2.56%
-0.79%
1-Year Price Total Return
-67.32%
-42.08%
Beta (5-Year)
0.159
0.660
Dividend yield:
0%
Annualized payout:
$0.00
Payout ratio:
--
Growth streak:
0 years
Technicals
8-day SMA
Sell
Level
$20.03
200-day SMA
Sell
Level
$34.19
Bollinger Bands (100)
Sell
Level
21.23 - 26.93
Chaikin Money Flow
Buy
Level
16M
20-day SMA
Buy
Level
$19.34
Relative Strength Index (RSI14)
Sell
Level
43.98
ADX Line
Sell
Level
17.86
Williams %R
Neutral
Level
-44.3864
50-day SMA
Sell
Level
$22.51
MACD (12, 26)
Sell
Level
-0.60
25-day Aroon Oscillator
Sell
Level
-52
On Balance Volume
Neutral
Level
21.4M
Financial Scores
Hold
Altman Z-Score
(Annual)
Level (2.1952)
Sell
CA Score
(Annual)
Level (-1.1729)
Buy
Beneish M-Score
(Annual)
Level (-3.6526)
Buy
Momentum Score
Level (2)
Sell
Ohlson Score
Level (0.4595)
Sell
Piotroski F Score
(Annual)
Level (3)
Buy
Quality Ratio Score
Level (5)
Buy
Fundamental Score
Level (8)
Revenue Forecast
Earnings per Share Forecast
Company Profile
AMN Healthcare Services Inc provides healthcare workforce solutions and staffing services in the United States. Its comprehensive suite of talent solutions provides management, staffing, recruitment, language services, technology, predictive and market analytics, and related services to build and manage all or parts of the clients’ healthcare workforce needs. Its reportable segments are; nurse and allied solutions, physician and leadership solutions, and technology and workforce solutions. A majority of its revenue is generated from the nurse and allied solutions segment which includes the company's travel nurse staffing, labor disruption staffing, local staffing, international nurse permanent placement, and allied staffing (including revenue cycle solutions) businesses.
Stock Forecast FAQ
In the current month, AMN has received 1 Buy ratings 5 Hold ratings, and 0 Sell ratings. The AMN average analyst price target in the past 3 months is $28.57.
-
Where Will AMN Healthcare Services Stock Be In 1 Year?
According to analysts, the consensus estimate is that AMN Healthcare Services share price will rise to $28.57 per share over the next 12 months.
-
What Do Analysts Say About AMN Healthcare Services?
Analysts are divided on their view about AMN Healthcare Services share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that AMN Healthcare Services is a Sell and believe this share price will drop from its current level to $25.00.
-
What Is AMN Healthcare Services's Price Target?
The price target for AMN Healthcare Services over the next 1-year time period is forecast to be $28.57 according to 6 Wall Street analysts, 1 of them rates the stock a Buy, 0 rate the stock a Sell, and 5 analysts rate the stock a Hold.
-
Is AMN A Buy, Sell Or Hold?
According to Wall Street analysts, the consensus rating for AMN Healthcare Services is a Hold. 5 of 6 analysts rate the stock a Hold at this time.
-
How Can I Buy Shares Of AMN?
You can purchase shares of AMN Healthcare Services via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, tastytrade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase AMN Healthcare Services shares.
-
What Is The AMN Healthcare Services Share Price Today?
AMN Healthcare Services was last trading at $19.63 per share. This represents the most recent stock quote for AMN Healthcare Services. Yesterday, AMN Healthcare Services closed at $19.58 per share.
-
How To Buy AMN Healthcare Services Stock Online?
In order to purchase AMN Healthcare Services stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is it Safe to Invest in Google With OpenAI Threats?
For the last 20 years, Google parent company Alphabet (NASDAQ:GOOG,…
Is Broadcom Stock a Millionaire Maker?
Broadcom (Nasdaq: AVGO) stock has gone up more than 64%…
Stock Ideas
Buy
70
Is MSFT Stock a Buy?
Market Cap: $3.2T
P/E Ratio: 37x
Sell
40
Is AAPL Stock a Buy?
Market Cap: $3T
P/E Ratio: 33x
Buy
60
Is NVDA Stock a Buy?
Market Cap: $2.8T
P/E Ratio: 39x
Alerts
Buy
60
RGC alert for May 7
Regencell Bioscience Holdings [RGC] is up 22.52% over the past day.
Buy
77
FARO alert for May 7
Faro Technologies [FARO] is down 0% over the past day.
Buy
53
SRPT alert for May 7
Sarepta Therapeutics [SRPT] is down 21.54% over the past day.
